Quantcast
Channel: Wayne Rhoads – Zolmax
Viewing all articles
Browse latest Browse all 192999

Geneos Wealth Management Inc. Reduces Position in Houlihan Lokey, Inc. (NYSE:HLI)

$
0
0

Houlihan Lokey logoGeneos Wealth Management Inc. lessened its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 3.8% in the first quarter, HoldingsChannel.com reports. The firm owned 15,315 shares of the financial services provider’s stock after selling 604 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Houlihan Lokey were worth $1,014,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Arkadios Wealth Advisors purchased a new stake in shares of Houlihan Lokey during the first quarter valued at approximately $32,000. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Houlihan Lokey in the first quarter worth $151,000. Meeder Asset Management Inc. purchased a new stake in Houlihan Lokey in the first quarter worth $59,000. Bessemer Group Inc. lifted its stake in Houlihan Lokey by 1,766.7% in the first quarter. Bessemer Group Inc. now owns 1,064 shares of the financial services provider’s stock worth $71,000 after acquiring an additional 1,007 shares during the period. Finally, Quantbot Technologies LP purchased a new stake in Houlihan Lokey in the first quarter worth $163,000. 75.62% of the stock is owned by hedge funds and other institutional investors.

In other news, Chairman Irwin Gold sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 1st. The stock was sold at an average price of $75.24, for a total transaction of $752,400.00. Following the transaction, the chairman now owns 10,000 shares of the company’s stock, valued at approximately $752,400. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Scott Joseph Adelson sold 12,383 shares of the business’s stock in a transaction that occurred on Tuesday, June 1st. The shares were sold at an average price of $75.00, for a total value of $928,725.00. Following the transaction, the insider now directly owns 12,383 shares in the company, valued at approximately $928,725. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 31,923 shares of company stock worth $2,445,675. Insiders own 26.02% of the company’s stock.

Houlihan Lokey stock opened at $89.10 on Monday. Houlihan Lokey, Inc. has a one year low of $54.12 and a one year high of $89.86. The stock has a market capitalization of $6.08 billion, a PE ratio of 19.41 and a beta of 0.67. The firm’s fifty day simple moving average is $79.85.

Houlihan Lokey (NYSE:HLI) last announced its earnings results on Tuesday, May 11th. The financial services provider reported $1.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.37. The business had revenue of $500.70 million for the quarter, compared to analysts’ expectations of $385.37 million. Houlihan Lokey had a return on equity of 24.41% and a net margin of 20.50%. The business’s revenue for the quarter was up 65.4% on a year-over-year basis. During the same period last year, the firm posted $0.96 earnings per share. Equities analysts expect that Houlihan Lokey, Inc. will post 4.27 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 15th. Stockholders of record on Wednesday, June 2nd were given a dividend of $0.43 per share. This is a boost from Houlihan Lokey’s previous quarterly dividend of $0.33. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend was Tuesday, June 1st. Houlihan Lokey’s payout ratio is presently 37.23%.

A number of brokerages recently commented on HLI. Zacks Investment Research raised Houlihan Lokey from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a research note on Tuesday, July 13th. Keefe, Bruyette & Woods lowered Houlihan Lokey from a “market perform” rating to an “underperform” rating and set a $80.00 price target for the company. in a research note on Wednesday, July 14th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $74.17.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.

Read More: Yield Curve

Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI).

Institutional Ownership by Quarter for Houlihan Lokey (NYSE:HLI)


Viewing all articles
Browse latest Browse all 192999

Trending Articles